22-46237885-G-A

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005036.6(PPARA):​c.*2505G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.309 in 152,270 control chromosomes in the GnomAD database, including 11,469 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.31 ( 11468 hom., cov: 32)
Exomes 𝑓: 0.15 ( 1 hom. )

Consequence

PPARA
NM_005036.6 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.12
Variant links:
Genes affected
PPARA (HGNC:9232): (peroxisome proliferator activated receptor alpha) Peroxisome proliferators include hypolipidemic drugs, herbicides, leukotriene antagonists, and plasticizers; this term arises because they induce an increase in the size and number of peroxisomes. Peroxisomes are subcellular organelles found in plants and animals that contain enzymes for respiration and for cholesterol and lipid metabolism. The action of peroxisome proliferators is thought to be mediated via specific receptors, called PPARs, which belong to the steroid hormone receptor superfamily. PPARs affect the expression of target genes involved in cell proliferation, cell differentiation and in immune and inflammation responses. Three closely related subtypes (alpha, beta/delta, and gamma) have been identified. This gene encodes the subtype PPAR-alpha, which is a nuclear transcription factor. Multiple alternatively spliced transcript variants have been described for this gene, although the full-length nature of only two has been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.674 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PPARANM_005036.6 linkuse as main transcriptc.*2505G>A 3_prime_UTR_variant 9/9 ENST00000407236.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PPARAENST00000407236.6 linkuse as main transcriptc.*2505G>A 3_prime_UTR_variant 9/91 NM_005036.6 P1Q07869-1

Frequencies

GnomAD3 genomes
AF:
0.309
AC:
46975
AN:
152068
Hom.:
11430
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.680
Gnomad AMI
AF:
0.271
Gnomad AMR
AF:
0.193
Gnomad ASJ
AF:
0.159
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0871
Gnomad FIN
AF:
0.139
Gnomad MID
AF:
0.218
Gnomad NFE
AF:
0.185
Gnomad OTH
AF:
0.263
GnomAD4 exome
AF:
0.155
AC:
13
AN:
84
Hom.:
1
Cov.:
0
AF XY:
0.191
AC XY:
13
AN XY:
68
show subpopulations
Gnomad4 AFR exome
AF:
1.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.177
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.309
AC:
47053
AN:
152186
Hom.:
11468
Cov.:
32
AF XY:
0.300
AC XY:
22292
AN XY:
74408
show subpopulations
Gnomad4 AFR
AF:
0.680
Gnomad4 AMR
AF:
0.192
Gnomad4 ASJ
AF:
0.159
Gnomad4 EAS
AF:
0.00116
Gnomad4 SAS
AF:
0.0857
Gnomad4 FIN
AF:
0.139
Gnomad4 NFE
AF:
0.185
Gnomad4 OTH
AF:
0.260
Alfa
AF:
0.187
Hom.:
3218
Bravo
AF:
0.329
Asia WGS
AF:
0.0820
AC:
288
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.24
DANN
Benign
0.43

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6008259; hg19: chr22-46633782; API